Indication of glucocorticoid pulses for patients with SARS-CoV-2 infection.
作者信息
Blasco Patiño Felipe, Guillamón Sánchez Ana Elena
机构信息
Unidad de Diagnóstico Médico y Enfermedades Minoritarias, Servicio de Medicina Interna, Hospital General Universitario de Torrevieja, Torrevieja, Alicante, Spain.
出版信息
Med Clin (Engl Ed). 2021 Apr 9;156(7):360. doi: 10.1016/j.medcle.2020.06.035. Epub 2021 Mar 3.
Abstract
摘要
相似文献
1
Indication of glucocorticoid pulses for patients with SARS-CoV-2 infection.糖皮质激素脉冲疗法对新型冠状病毒2型感染患者的适应证。
Med Clin (Engl Ed). 2021 Apr 9;156(7):360. doi: 10.1016/j.medcle.2020.06.035. Epub 2021 Mar 3.
2
Indication of glucocorticoid pulses for patients with SARS-CoV-2 infection.新型冠状病毒2019感染患者使用糖皮质激素冲击治疗的指征。
Med Clin (Barc). 2021 Apr 9;156(7):360. doi: 10.1016/j.medcli.2020.06.041. Epub 2020 Jul 28.
3
Postoperative mortality and complications in patients with and without pre-operative SARS-CoV-2 infection: a service evaluation of 24 million linked records using OpenSAFELY.术前 SARS-CoV-2 感染患者与非感染患者的术后死亡率和并发症：使用 OpenSAFELY 对 2400 万份关联记录进行的服务评估。
Anaesthesia. 2023 Jun;78(6):692-700. doi: 10.1111/anae.16001. Epub 2023 Mar 23.
4
A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.一项回顾性对照队列研究，探讨糖皮质激素治疗对 SARS-CoV-2 感染死亡率的影响。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01168-20.
5
[Evolution and treatment of storm cytoquine syndrome associated to SARS-CoV-2 infection among octogenarians].[老年人群中与SARS-CoV-2感染相关的暴发性细胞因子综合征的演变与治疗]
Rev Esp Geriatr Gerontol. 2020 Sep-Oct;55(5):286-288. doi: 10.1016/j.regg.2020.05.004. Epub 2020 Jun 3.
6
A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.一种新型糖皮质激素和雄激素受体调节剂可降低 SARS-CoV-2 感染叙利亚仓鼠模型中的病毒进入和固有免疫炎症反应。
Front Immunol. 2022 Feb 16;13:811430. doi: 10.3389/fimmu.2022.811430. eCollection 2022.
7
Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection.预测 SARS-CoV-2 感染患者对甲基强的松龙脉冲治疗的反应。
Med Clin (Barc). 2022 Dec 23;159(12):557-562. doi: 10.1016/j.medcli.2022.02.025. Epub 2022 Jun 17.
8
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.COVID-19 肺炎的糖皮质激素（CORTIVID）治疗：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.
9
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review.新冠病毒感染能否引发系统性红斑狼疮？基于病例的综述。
Rheumatol Int. 2021 Apr;41(4):799-809. doi: 10.1007/s00296-021-04794-7. Epub 2021 Feb 4.
10
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.新型冠状病毒肺炎与下丘脑-垂体-肾上腺轴的关系：从糖皮质激素不足到过度的大谱- CAPISCO 国际专家小组。
Int J Mol Sci. 2022 Jun 30;23(13):7326. doi: 10.3390/ijms23137326.
本文引用的文献
1
Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection.COVID-19 相关细胞因子风暴综合征患者应用皮质激素脉冲治疗的效果。
Med Clin (Barc). 2020 Aug 28;155(4):159-161. doi: 10.1016/j.medcli.2020.04.018. Epub 2020 May 27.
2
Viral dynamics in mild and severe cases of COVID-19.新冠肺炎轻症和重症病例中的病毒动力学
Lancet Infect Dis. 2020 Jun;20(6):656-657. doi: 10.1016/S1473-3099(20)30232-2. Epub 2020 Mar 19.
3
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
4
Innate immune evasion strategies of DNA and RNA viruses.DNA和RNA病毒的天然免疫逃避策略
Curr Opin Microbiol. 2016 Aug;32:113-119. doi: 10.1016/j.mib.2016.05.015. Epub 2016 Jun 8.
Zotero 插件